Subtype
Neuroblastoma
CI-CAN-00003408Explore in graph →
137 active trials3 approved drugs27 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003408Explore in graph →
Clinical trials
616 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (80)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002740 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma | completed | Phase 1 | 30 | Children's Oncology GroupNETWORK | 1 | Jul 24, 2014 | clinicaltrials |
| NCT00217412 | Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 |
| clinicaltrials |
| NCT00003141 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors | completed | Phase 1 | 94 | Children's Oncology GroupNETWORK | 3 | Mar 28, 2014 | clinicaltrials |
| NCT00002485 | Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer | completed | — | 359 | Children's Oncology GroupNETWORK | 4 | Feb 14, 2014 | clinicaltrials |
| NCT00017368 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | completed | Phase 2 | 42 | Children's Oncology GroupNETWORK | 2 | Feb 13, 2014 | clinicaltrials |
| NCT00070200 | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | completed | Phase 1 | 31 | Children's Oncology GroupNETWORK | 2 | Feb 13, 2014 | clinicaltrials |
| NCT01048892 | Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | completed | Phase 1 | 22 | Children's Oncology GroupNETWORK | 1 | Jan 30, 2014 | clinicaltrials |
| NCT00002802 | Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma | completed | Phase 3 | 500 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002803 | Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma | completed | Phase 2 | 44 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00028522 | R(+)XK469 in Treating Patients With Advanced Neuroblastoma | completed | Phase 1 | 85 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00025428 | Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | completed | Phase 3 | 100 | Societe Internationale d'Oncologie PediatriqueOTHER | 12 | Dec 4, 2013 | clinicaltrials |
| NCT00004110 | Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00450307 | Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma | completed | Phase 1 | 32 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00053326 | Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00075634 | Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00025597 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025610 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025623 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025649 | Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00276679 | Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma | completed | Phase 2 | — | Children's Cancer and Leukaemia GroupOTHER | 3 | Sep 17, 2013 | clinicaltrials |
| NCT00003203 | Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors | completed | Phase 2 | 168 | Children's Oncology GroupNETWORK | 3 | Aug 23, 2013 | clinicaltrials |
| NCT00017225 | Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | completed | Phase 2 | — | German Society for Pediatric Oncology and Hematology GPOH gGmbHOTHER | 3 | Aug 2, 2013 | clinicaltrials |
| NCT00206388 | Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement | completed | Phase 1 | 21 | Baylor College of MedicineOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00365755 | Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma | completed | Phase 3 | — | Children's Cancer and Leukaemia GroupOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00002543 | Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | completed | Phase 1 | 3 | Medical College of WisconsinOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00112645 | Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 10 | Milton S. Hershey Medical CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00002634 | Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003022 | Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00012181 | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00002560 | Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma | completed | Phase 2 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT01095926 | Pharmacokinetic Study of Doxorubicin in Children With Cancer(Doxo) | completed | Phase 2 | 101 | University Hospital MuensterOTHER | 4 | Jun 28, 2013 | clinicaltrials |
| NCT00003737 | Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma | completed | Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00002515 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005955 | Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors | completed | Phase 2 | — | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00020527 | Caspofungin Acetate in Treating Children With Fever and Neutropenia | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00066599 | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00004078 | Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 2 | 181 | Children's Oncology GroupNETWORK | 1 | Jun 14, 2013 | clinicaltrials |
| NCT00002458 | Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00077454 | Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 95 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00093821 | Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors | completed | Phase 1 | 70 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00040911 | Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma | completed | N/A | 17 | Children's Oncology GroupNETWORK | 1 | May 31, 2013 | clinicaltrials |
| NCT00004188 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | completed | Phase 3 | 495 | Children's Oncology GroupNETWORK | 2 | May 17, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00060372 | Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00003408 | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer | completed | Phase 2 | 40 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00040872 | Multiple Therapies in Treating Patients With Advanced Neuroblastoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT00471679 | Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Jul 24, 2014source: clinicaltrials